Atlas Venture Fund X L.P. 13D and 13G filings for Ikena Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 5:12 pm Purchase | 2021-03-30 | 13D | Ikena Oncology, Inc. IKNA | Atlas Venture Fund X L.P. | 2,901,609 8.100% | 2,901,609 (New Position) | Filing |